Melanoma-associated retinopathy: Screening for melanoma-associated retinopathy in patients with cutaneous malignant melanoma

Neuro-Ophthalmology

Volumn 27, Issue 1-3, 2002, Pages 121-137

  Haus, Arno H ^a   Palmowski, Anja M ^a,c   Pföhler, Claudia ^a   Reinhold, Uwe ^a   Gantenbein, Claude ^a   Thirkill, Charles E ^b   Allgayer, Rainer ^a   Tilgen, Wolfgang ^a   Ruprecht, Klaus W ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY EYE CLINIC   (Switzerland)

Author keywords

Antiretinal antibodies; Color vision; Cutaneous malignant melanoma; Melanoma associated retinopathy; Scotopic b wave

Indexed keywords

ANTIBODY; RETINA ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANAMNESIS; CLINICAL ARTICLE; COLOR VISION TEST; CONFERENCE PAPER; CONTRAST SENSITIVITY; DISEASE ASSOCIATION; ELECTROPHYSIOLOGY; FARNSWORTH PANEL D 15 COLOR TEST; GERMANY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MELANOMA ASSOCIATED RETINOPATHY; OPHTHALMOLOGY; PARANEOPLASTIC SYNDROME; PERIMETRY; PREVALENCE; RETINA BIPOLAR GANGLION CELL; RETINOPATHY; SCREENING TEST;

EID: 0038126917     PISSN: 01658107     EISSN: None     Source Type: Journal    
DOI: 10.1076/noph.27.1.121.14294     Document Type: Conference Paper

References (57)

1. Berson EL, Lessell S. Paraneoplastic night blindness with malignant melanoma. Am J Ophthalmol. 1988;106:307-311.
2. Alexander KR, Fishman GA, Peachey NS, Marchese AL, Tso MO. 'On' response defect in paraneoplastic night blindness with cutaneous malignant melanoma. Invest Ophthalmol Vis Sci. 1992;33:477-483.
3. Gittinger Jr JW, Smith TW. Cutaneous melanoma-associated paraneoplastic retinopathy: histopathologic observations. Am J Ophthalmol. 1999;127:612-614.
4. Okel BB, Thirkill CE, Alexander K. An unusual case of melanoma-associated retinopathy. Ocul Immunol Inflamm. 1995;3:121-127.
5. Weinstein JM, Kelman SE, Bresnick GH, Kornguth SE. Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma. Ophthalmology. 1994;101:1236-1243.
6. Milam AH, Saari JC, Jacobson SG, Lubinsci WP, Feun LG, Alexander KR. Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci. 1993;34:91-100.
7. Ohguro H, Milam AH. A retinal bipolar cell protein is recognized by autoantibodies from patients with melanoma-associated retinopathy (ARVO Abstract). Invest Ophthalmol Vis Sci. 1999;S153.
8. Keltner JL, Thirkill CE. The 22-kDa antigen in optic nerve and retinal diseases. J Neuro-ophthalmol. 1999;19:71-83.
9. Flynn MF, Fishman GA, Adamus G. Antiretinal Müller cell antibodies in patients with melanoma associated and autoimmune retinopathy (ARVO Abstract). Invest Ophthalmol Vis Sci. 2000;S567.
10. Bret-Dibat C, Rougier MB, Le-Rebeller MJ, Delaunay M. Melanoma-associated retinopathy. Apropos of a case and review of the literature. Bull Cancer. 1996;83:1019-1022.
11. Kim RY, Retsas S, Fitzke FW, Arden GB, Bird AC. Cutaneous melanoma-associated retinopathy. Ophthalmology. 1994;101:1837-1843.
12. Andreasson S, Ponjavic V, Ehinger B. Full-field electroretinogram in a patient with cutaneous melanoma-associated retinopathy. Acta Ophthalmol Copenh. 1993;71:487-490.
13. Potter MJ, Thirkill CE, Dam OM, Lee AS, Milam AH. Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy. Ophthalmology. 1999;106:2121-2125.
14. Vaphiades MS, Brown H, Whitcup SM. Node way out. Surv Ophthalmol. 2000;45:77-78.
15. Kellner U, Bornfeld N, Foerster MH. Severe course of cutaneous melanoma associated paraneoplastic retinopathy. Br J Ophthalmol. 1995;79:746-752.
16. Rougier MB, Hostyn P, Bret-Dibat C, Delaunay MM, Riss I, Le-Rebeller MJ. Melanoma-associated paraneoplastic retinopathy: a case report and update. J Fr Ophthalmol. 1995;18:396-403.
17. Remulla JF, Pineda R, Gaudio AR, Milam AH. Cutaneous melanoma-associated retinopathy with retinal periphlebitis (Letter). Arch Ophthalmol. 1995;113:854-855.
18. Boeck K, Hofmann S, Klopfer M, Ugi I, Schmidt T, Engst R, Thirkill CE, Ring J. Melanoma-associated paraneoplastic retinopathy: case report and review of the literature. Br J Dermatol. 1997;137:457-460.
19. Rush JA. Paraneoplastic retinopathy in malignant melanoma (Letter). Am J Ophthalmol. 1993;115:390-391.
20. Klopfer M, Schmidt T, Leipert KP, Ugi I, Boeck K, Hofmann S. Melanoma-associated retinopathy accompanied by night blindness - a case report. Ophthalmologe. 1997;94:563-567.
21. Singh AD, Milam AH, Shields CL, De-Potter P, Shields JA. Melanoma-associated retinopathy. Am J Ophthalmol. 1995;119:369-370.
22. Kiratli H, Thirkill CE, Bilgic S, Eldem B, Kececi A. Paraneoplastic retinopathy associated with metastatic cutaneous melanoma of unknown primary site. Eye. 1997;11:889-892.
23. Holder GE. Electrophysiological features of melanoma associated retinopathy (MAR) (ARVO Abstract). Invest Ophthalmol Vis Sci. 2000;S568.
24. Wolf JE, Arden GB. Selective magnocellular damage in melanoma-associated retinopathy: comparison with congenital stationary night blindness. Vision Res. 1996;36:2369-2379.
25. Feigl B, Faschinger C, Soyer P. Melanoma-associated retinopathy versus abnormal retinal function due to interferon-alpha/isoretinoin therapy in cutaneous malignant melanoma. Ophthalmologica. 2000;214:271-276.
26. Wolf JE, Arden GB, Plant GT. Selective damage to either the 'M' or 'P' cell pathway in human retinal disease: implications for visual processing. Eur J Ophthalmol. 1996;6:208-214.
27. Janaky M, Palffy A, Kolozsvari L, Benedek G. Unilateral manifestation of melanoma-associated retinopathy. Arch Ophthalmol. 2002;120:866-867.
28. Potter MJ, Adamus G, Szabo SM, Lee R, Mohaseb K, Behn D. Autobodies to transducin in a patient with melanoma-associated retinopathy. Am J Ophthalmol. 2002;134:128-130.
29. Keltner JL, Thirkill CE, Yip PT. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. J Neuroophthalmol. 2001;21:173-187.
30. Gass JDM. Acute Vogt-Koyanagi-Harada like syndrome occurring in a patient with metastatic cutaneous melanoma. In: Saari KH, editor. Uveitis update: proceedings of the international symposium on uveitis. Amsterdam: Elsevier, 1984;407-408.
31. Ripps H, Carr RE, Siegel IM, Greenstein VC. Functional abnormalities in vincristine-induced night blindness. Invest Ophthalmol Vis Sci. 1984;25:787-794.
32. Dubois LG, Sadun AA, Lawton TB. Inner retinal layer loss in complicated migraine. Case report. Arch Ophthalmol. 1988;106:1035-1037.
33. Dubois LG, Sadun AA. Retinitis pigmentosa misdiagnosed as complicated migraine. In reply. Arch Ophthalmol. 1991;109:175.
34. Steel DHW, Mahomed I, Shefield E. Unilateral choroidal melanoma with bilateral retinal vasculitis. Br J Ophthalmol. 1996;80:850-851.
35. Zacks DN, Pinnolis MK, Berson EL, Gragoudas ES. Melanoma-associated retinopathy and recurrent exsudative retinal detachments in a patient with choroidal melanoma. Am J Ophthalmol. 2001;132:578-581.
36. Daw NW, Jensen RJ, Brunken WJ. Rod pathways in mammalian retinae. Trends Neurosci. 1990;13:110-115.
37. Sharpe LT, Stockman A. Rod pathways: the importance of seeing nothing. Trends Neurosci. 1999;22:497-504.
38. Thirkill CE. Retinal pigment epithelial hypersensitivity, an association with vision loss: RPE hypersensitivity complicating paraneoplastic retinopathies. Ocul Immunol Inflamm. 2000;8:25-37.
39. Alexander KR, Fishman GA, Swinfard RW, Misfeldt ML, Milam AH. Sinclair swine with spontaneously regressing cutaneous melanomas do not have autoantibodies against retinal bipolar cells. Exp Eye Res. 1996;63:347-349.
40. Lei B, Bush RA, Milam AH, Sieving PA. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci. 2000;41:262-166.
41. Pföhler C, Thirkill CE, Palmowski A, Haus A, Tilgen W, Reinhold U. Identification of antibodies in serum of patients with melanoma-associated retinopathy (Abstract). In: The 8th world congress on cancers of the skin, Zurich, July 18-21, 2001, P44.
42. Palmowski AM, Haus AH, Pföhler C, Reinhold U, Allgayer R, Tilgen W, Ruprecht KW, Thirkill CE. Bilateral multifocal chorioretinopathy in a woman with cutaneous malignant melanoma. Arch Ophthalmol. 2002;120:1756-1761.
43. Chan C, O'Day J. Melanoma-associated retinopathy: does autoimmunity prolong survival? Clin Exp Ophthalmol. 2001;29:235-238.
44. Guilino G, Wieczorek HL. Anforderungen an die Übung der Nachtfahrtauglichkeit und eine neue technische Möglichkeit für ihre Durchführung. Augenarzt. 1979;3:224-238.
45. Sutter EE, Tran D. The field topography of ERG components in man. I. The photopic luminance response. Vision Res. 1992;32:433-446.
46. Gloor B, Robert Y. Versicherung und Begutachtung. In: Gloor B, editor. Perimetrie mit besonderer Berücksichtigung der automatischen Perimetrie. Stuttgart: Enke, 1993.
47. Egge K. The visual field in normal subjects. Acta Ophthalmol Suppl. 1984;169:1-64.
48. Thirkill CE, Roth AM, Keltner JL. Cancer-associated retinopathy. Arch Ophthalmol. 1987;105:372-375.
49. Kawabata H, Adachi-Usami E. Multifocal electroretinogram in myopia. Invest Ophthalmol Vis Sci. 1997;38:2844-2851.
50. Dawson WW, Jordan BL, Marsh RD, Hazariwala K, Flowers FP, Fang T. Distant cancer effects on standardized testing of peripheral vision. Br J Ophthalmol. 2001;85:291-296.
51. Guyer DR, Tiedeman J, Yannuzzi LA, Slakter JS, Parke D, Kelley J,Tang RA, Marmor M, Abrams G, Miller JW, et al. Interferon-associated retinopathy. Arch Ophthalmol. 1993;111:350-356.
52. Hayasaka S, Nagaki Y, Matsumoto M, Sato S. Interferon associated retinopathy. Br J Ophthalmol. 1998;82:323-325.
53. Moschos M, Manesis EK, Panagakis E, Brouzas D, Hadziyannis S, Theodossiadis G. The effect of low dose interferon treatment on visual evoked potentials. Doc Ophthalmol. 1998;94:215-221.
54. Padmos P, Van Norren D, Faijer JW. Blue cone function in a family with an inherited tritan defect, tested with electroretinography and psychophysics. Invest Ophthalmol Vis Sci. 1978;17:436-441.
55. Shinzato K, Yokoyama M, Uji Y, Ichikawa H. The electroretinographic characteristics of congenital tritan defects. Doc Ophthalmol. 1986;62:19-24.
56. Eckstein AK, Reichenbach A, Jacobi P, Weber P, Gregor M, Zrenner E. Hepatic retinopathia. Changes in retinal function. Vision Res. 1997;39:1699-1706.
57. Lehnert W, Schmidt J. Nyctometry findings in different age groups. Z Altersforsch. 1967;20:27-34.